Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Activation of murine pre-proglucagon–producing neurons reduces food intake and body weight
Ronald P. Gaykema, … , Kevin W. Williams, Michael M. Scott
Ronald P. Gaykema, … , Kevin W. Williams, Michael M. Scott
Published February 20, 2017
Citation Information: J Clin Invest. 2017;127(3):1031-1045. https://doi.org/10.1172/JCI81335.
View: Text | PDF
Research Article Metabolism Neuroscience

Activation of murine pre-proglucagon–producing neurons reduces food intake and body weight

  • Text
  • PDF
Abstract

Peptides derived from pre-proglucagon (GCG peptides) act in both the periphery and the CNS to change food intake, glucose homeostasis, and metabolic rate while playing a role in anxiety behaviors and physiological responses to stress. Although the actions of GCG peptides produced in the gut and pancreas are well described, the role of glutamatergic GGC peptide–secreting hindbrain neurons in regulating metabolic homeostasis has not been investigated. Here, we have shown that chemogenetic stimulation of GCG-producing neurons reduces metabolic rate and food intake in fed and fasted states and suppresses glucose production without an effect on glucose uptake. Stimulation of GCG neurons had no effect on corticosterone secretion, body weight, or conditioned taste aversion. In the diet-induced obese state, the effects of GCG neuronal stimulation on gluconeogenesis were lost, while the food intake–lowering effects remained, resulting in reductions in body weight and adiposity. Our work suggests that GCG peptide–expressing neurons can alter feeding, metabolic rate, and glucose production independent of their effects on hypothalamic pituitary-adrenal (HPA) axis activation, aversive conditioning, or insulin secretion. We conclude that GCG neurons likely stimulate separate populations of downstream cells to produce a change in food intake and glucose homeostasis and that these effects depend on the metabolic state of the animal.

Authors

Ronald P. Gaykema, Brandon A. Newmyer, Matteo Ottolini, Vidisha Raje, Daniel M. Warthen, Philip S. Lambeth, Maria Niccum, Ting Yao, Yiru Huang, Ira G. Schulman, Thurl E. Harris, Manoj K. Patel, Kevin W. Williams, Michael M. Scott

×

Figure 3

CNO application produces a small increase in GCG neuronal resting membrane potential and increases firing frequency following current injection.

Options: View larger image (or click on image) Download as PowerPoint
CNO application produces a small increase in GCG neuronal resting membra...
CNO elevates resting membrane potential and potentiates action potential firing in mCherry-labeled neurons in the NTS following current injection. Recordings were made from tissue sections from 4 animals. (A) mCherry expression within the NTS. AP, area postrema; cc, central canal. (B) Patch clamped mCherry neuron. (C and D) Representative traces showing that bath application of CNO (9 μM; 10 minutes) evoked firing in mCherry-labeled neurons. (E) An expanded trace showing a single depolarizing event with spikes during perfusion of CNO (9 μM). Resting membrane potential was increased by 6 mV, an effect that led to a minimal increase in spontaneous firing rate. ACSF, artificial cerebrospinal fluid. (F) Labeled neurons did not fire action potentials in the absence of CNO. (G) CNO (9 μM) did not evoke spikes in unlabeled neurons. Breaks shown represent 2 minutes of duration. Spikes elicited by a depolarized current injection step to 110 pA in labeled neurons before (H) and after 10 minutes of CNO (9 μM) application (I). (J) Plot of firing frequency as a function of increasing depolarizing current steps shows a significant increase in firing frequency in labeled neurons after 10 minutes of CNO application (9 μM; 2-way repeated measures ANOVA, main effect of CNO treatment, F1,10 = 7.782, P = 0.019). Spikes elicited by a depolarized current injection step to 110 pA in unlabeled neurons before (K) and (L) after 10 minutes of CNO (9 μM) application. (M) Plot of firing frequency as a function of increasing depolarizing current steps shows no change in firing frequency in unlabeled neurons after 10 minutes of CNO (9 μM; n = 5). Values represent mean ± SEM. *P < 0.05.

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts